Rosiglitazone

insulin like growth factor 1 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34485865 Treatment of acromegaly by rosiglitazone via upregulating 15-PGDH in both pituitary adenoma and liver. 2021 Sep 24 3
2 30121911 Modulation of the Inflammatory Status of Macrophages and Their Paracrine Effect on the Sensitivity of Adipocytes to Insulin with Sirtuin and PPARγ Receptor Activators. 2018 Aug 1
3 25050627 Rosiglitazone suppresses angiogenesis in multiple myeloma via downregulation of hypoxia-inducible factor-1α and insulin-like growth factor-1 mRNA expression. 2014 Oct 1
4 25052610 [Effect of rosiglitazone on the expression of HIF1α and IGF1 mRNA in myeloma]. 2014 Jul 2
5 23864113 Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation. 2013 Sep 7
6 22473412 Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study. 2012 1
7 23053988 Roles of α-linolenic acid on IGF-I secretion and GH/IGF system gene expression in porcine primary hepatocytes. 2012 Dec 1
8 20671417 Effect of rosiglitazone on serum IGF-I concentrations in uncontrolled acromegalic patients under conventional medical therapy: results from a pilot phase 2 study. 2011 Feb 6
9 18475308 Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells. 2008 Jul-Aug 1
10 17122083 Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo. 2007 Feb 2
11 17309144 Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly. 2007 Feb 2
12 16777971 Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells. 2006 Sep 1
13 12593999 Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy. 2003 Feb 2